Pasar al contenido principal

REGULACION DE LA LINFOMAGENESIS, EL CRECIMIENTO INDEPENDIENTE DE ANCLAJE Y LA INVASIVIDAD DE LOS TUMORES LINFOIDES POR CDCA7

SAF2017-88881-R

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2017
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

CDCA7 is a critical mediator of lymphomagenesis that selectively regulates anchorage-independent growth

  • Jiménez Pérez, Raúl
  • Martín-Cortázar, Carla
  • Kourani, Omar
  • Chiodo, Yuri
  • Córdoba, Raúl
  • Domínguez-Franjo, María Purificación
  • Redondo, Juan Miguel
  • Iglesias, Teresa
  • Campanero, Miguel R.
Tumor formation involves the acquisition of numerous capacities along the progression from a normal cell into a malignant cell, including limitless proliferation (immortalization) and anchorage-independent growth, a capacity that correlates extremely well with tumorigenesis. Great efforts have been made to uncover genes involved in tumor formation, but most genes identified participate in processes related to cell proliferation. Accordingly, therapies targeting these genes also affect the proliferation of normal cells. To identify potential targets for therapeutic intervention more specific to tumor cells, we looked for genes implicated in the acquisition of anchorage-independent growth and in vivo tumorigenesis capacity. A transcriptomic analysis identified CDCA7 as a candidate gene. Indeed, CDCA7 protein was upregulated in Burkitt's lymphoma cell lines and human tumor biopsy specimens relative to control cell lines and tissues, respectively. CDCA7 levels were also markedly elevated in numerous T and B-lymphoid tumor cell lines. While CDCA7 was not required for anchorage-dependent growth of normal fibroblasts or non-malignant lymphocytes, it was essential but not sufficient for anchorage-independent growth of lymphoid tumor cells and for lymphomagenesis. These data suggest that therapies aimed at inhibiting CDCA7 expression or function might significantly decrease the growth of lymphoid tumors., This work was supported by the Spanish Ministerio de Economía, Industria y Competitividad (MEIC) grants to MRC. (SAF2013-45258P and SAF2017-88881-R) and TIV. (SAF2014-52737P); and by Instituto de Salud Carlos III (CIBERNED) to TIV. The cost of this publication has been paid in part with FEDER funds. OK holds an FPI fellowship from MEIC (BES-2014-069236). The CNIC is supported by the Ministerio de Ciencia, Investigación y Universidades and the Pro CNIC Foundation, and is a Severo Ochoa Center of Excellence (SEV-2015-0505)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Conditional deletion of Rcan1 predisposes to hypertension-mediated intramural hematoma and subsequent aneurysm and aortic rupture

  • Villahoz, Silvia
  • Yunes-Leites, Paula Sofía
  • Méndez-Barbero, Nerea
  • Urso, Katia
  • Bonzón-Kulichenko, Elena
  • Ortega, Elena
  • Nistal, J. Francisco
  • Vázquez, Jesús
  • Offermanns, Stefan
  • Redondo, Juan Miguel
  • Campanero, Miguel R.
Aortic intramural hematoma (IMH) can evolve toward reabsorption, dissection or aneurysm. Hypertension is the most common predisposing factor in IMH and aneurysm patients, and the hypertensive mediator angiotensin-II induces both in mice. We have previously shown that constitutive deletion of Rcan1 isoforms prevents Angiotensin II-induced aneurysm in mice. Here we generate mice conditionally lacking each isoform or all isoforms in vascular smooth muscle cells, endothelial cells, or ubiquitously, to determine the contribution to aneurysm development of Rcan1 isoforms in vascular cells. Surprisingly, conditional Rcan1 deletion in either vascular cell-type induces a hypercontractile phenotype and aortic medial layer disorganization, predisposing to hypertension-mediated aortic rupture, IMH, and aneurysm. These processes are blocked by ROCK inhibition. We find that Rcan1 associates with GSK-3β, whose inhibition decreases myosin activation. Our results identify potential therapeutic targets for intervention in IMH and aneurysm and call for caution when interpreting phenotypes of constitutively and inducibly deficient mice., CNIC is supported by the Spanish Ministerio de Ciencia, Investigación y Universidades (MINECO) and the Pro-CNIC Foundation, and is a Severo Ochoa Center of Excellence (SEV-2015-0505). Support was also provided by grants from MINECO (grants SAF2013- 45258P and SAF2017-88881R (M.R.C.), SAF2015-636333R (J.M.R.), PI15/01224 (J.F.N.), and BIO2015-67580-P (J.V.)), Comunidad de Madrid (grant AORTASANA-CM; B2017/ BMD-3676 (M.R.C. and J.M.R.)), CSIC (M.R.C.), Fundacion La Marato TV3 (grant 20151330 (J.M.R.)), The Marfan Foundation Faculty grant 2017 (J.M.R.), and the CIBERCV of Ministerio de Sanidad (grants CB16/11/00264 (J.M.R.) and CB16/11/00277 (J.V.)). S.V. and P.S.Y.-L. hold FPI fellowships SVP-2013-067777 and BES-2016-076637, respectively. The cost of this publication was paid in part with FEDER funds., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Differential regulation of Kidins220 isoforms in Huntington's disease

  • Sebastián-Serrano, Álvaro
  • Simón-García, Ana
  • Belmonte-Alfaro, Alicia
  • Pose-Utrilla, Julia
  • Santos-Galindo, María
  • Puerto, Ana del
  • García-Guerra, Lucía
  • Hernández, Ivó H.
  • Schiavo, Giampietro
  • Campanero, Miguel R.
  • Lucas, José Javier
  • Iglesias, Teresa
Huntington's disease (HD) is an inherited progressive neurodegenerative disease characterized by brain atrophy particularly in the striatum that produces motor impairment, and cognitive and psychiatric disturbances. Multiple pathogenic mechanisms have been proposed including dysfunctions in neurotrophic support and calpain-overactivation, among others. Kinase D-interacting substrate of 220 kDa (Kidins220), also known as ankyrin repeat-rich membrane spanning (ARMS), is an essential mediator of neurotrophin signaling. In adult brain, Kidins220 presents two main isoforms that differ in their carboxy-terminal length and critical protein-protein interaction domains. These variants are generated through alternative terminal exon splicing of the conventional exon 32 (Kidins220-C32) and the recently identified exon 33 (Kidins220-C33). The lack of domains encoded by exon 32 involved in key neuronal functions, including those controlling neurotrophin pathways, pointed to Kidins220-C33 as a form detrimental for neurons. However, the functional role of Kidins220-C33 in neurodegeneration or other pathologies, including HD, has not been explored. In the present work, we discover an unexpected selective downregulation of Kidins220-C33, in the striatum of HD patients, as well as in the R6/1 HD mouse model starting at early symptomatic stages. These changes are C33-specific as Kidins220-C32 variant remains unchanged. We also find the early decrease in Kidins220-C33 levels takes place in neurons, suggesting an unanticipated neuroprotective role for this isoform. Finally, using ex vivo assays and primary neurons, we demonstrate that Kidins220-C33 is downregulated by mechanisms that depend on the activation of the protease calpain. Altogether, these results strongly suggest that calpain-mediated Kidins220-C33 proteolysis modulates onset and/or progression of HD., This work was supported by the Spanish Ministerio de Ciencia, Innovación y Universidades (MCIU) grants to T.I. (SAF2017‐88885‐R), J.J.L. (SAF2015‐65371‐R) and M.R.C. (SAF2017‐88881‐R); by B2017/BMD‐3700 NEUROMETAB‐CM (Comunidad de Madrid, Madrid, Spain) to T.I. and institutional grants to CBMSO from Fundación Ramón Areces and Fundación Banco de Santander to J.J.L. T.I. and J.J.L. are also funded by Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED) and CIBERNED cooperative project 2015‐2/06 (Instituto de Salud Carlos III, Spain). GS work was supported by the Wellcome Trust Senior Investigator Award (107116/Z/15/Z), the European Union's Horizon 2020 Research and Innovation programme under grant agreement 739572 and a UK Dementia Research Institute Foundation award. A.S.‐S. was funded by a contract from CIBERNED‐2015‐2/06.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

CDCA7 finely tunes cytoskeleton dynamics to promote lymphoma migration and invasion

  • Martín-Cortázar, Carla
  • Chiodo, Yuri
  • Jiménez Pérez, Raúl
  • Bernabé, Manuel
  • Cayuela, María Luisa
  • Iglesias, Teresa
  • Campanero, Miguel R.
Metastases, the major cause of death from cancer, require cells’ acquisition of the ability to migrate and involve multiple steps, including local tumor cell invasion and basement membrane penetration. Certain lymphoid tumors are highly metastatic, but the mechanisms of invasion by lymphoma cells are poorly understood. We recently showed that CDCA7, a protein induced by MYC, is overexpressed in lymphoid tumors and that its knockdown decreases lymphoid tumor growth without inhibiting the proliferation of normal cells. Here we show that CDCA7 is critical for invasion and migration of lymphoma cells. Indeed, CDCA7 knockdown in lymphoma cells limited tumor cell invasion in matrigel-coated transwell plates and tumor invasion of neighboring tissues in a mouse xenograft model and in a zebrafish model of cell invasion. CDCA7 silencing markedly inhibited lymphoma cell migration on fibronectin without modifying cell adhesion to this protein. Instead, CDCA7 knockdown markedly disrupted the precise dynamic reorganization of actomyosin and tubulin cytoskeletons required for efficient migration. In particular, CDCA7 silencing impaired tubulin and actomyosin cytoskeleton polarization, increased filamentous actin formation, and induced myosin activation. Of note, inhibitors of actin polymerization, myosin II, or ROCK reestablished the migration capacity of CDCA7-silenced lymphoma cells. Given the critical role of CDCA7 in lymphoma-genesis and invasion, therapies aimed at inhibiting its expression or activity might provide significant control of lymphoma growth, invasion, and metastatic dissemination., The authors thank D. Trono for plasmids; the Spanish Ministerio de Economía y Competitividad for grants SAF2017-88881-R and SAF2017-88885-R (MINECO/AEI/FEDER, UE) to MRC and TIV, respectively; the Comunidad de Madrid for European Social Fund (ESF) cofinanced AORTASANA- CM; B2017/BMD- 3676 programme to MRC; and Instituto de Salud Carlos III (CIBERNED) for funding to TIV. The cost of this publication was paid in part with FEDER funds., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Kidins220 deficiency causes ventriculomegaly via SNX27-retromer-dependent AQP4 degradation

  • Puerto, Ana del
  • Pose-Utrilla, Julia
  • Simón-García, Ana
  • López-Menéndez, Celia
  • Jiménez, Antonio J.
  • Porlan, Eva
  • Pajuelo, Luis S. M.
  • Cano-García, Guillermo
  • Martí-Prado, Beatriz
  • Sebastián-Serrano, Álvaro
  • Sánchez-Carralero, Marina P.
  • Cesca, Fabrizia
  • Schiavo, Giampietro
  • Ferrer, Isidro
  • Fariñas, Isabel
  • Campanero, Miguel R.
  • Iglesias, Teresa
Several psychiatric, neurologic and neurodegenerative disorders present increased brain ventricles volume, being hydrocephalus the disease with the major manifestation of ventriculomegaly caused by the accumulation of high amounts of cerebrospinal fluid (CSF). The molecules and pathomechanisms underlying cerebral ventricular enlargement are widely unknown. Kinase D interacting substrate of 220 kDa (KIDINS220) gene has been recently associated with schizophrenia and with a novel syndrome characterized by spastic paraplegia, intellectual disability, nystagmus and obesity (SINO syndrome), diseases frequently occurring with ventriculomegaly. Here we show that Kidins220, a transmembrane protein effector of various key neuronal signalling pathways, is a critical regulator of CSF homeostasis. We observe that both KIDINS220 and the water channel aquaporin-4 (AQP4) are markedly downregulated at the ventricular ependymal lining of idiopathic normal pressure hydrocephalus (iNPH) patients. We also find that Kidins220 deficient mice develop ventriculomegaly accompanied by water dyshomeostasis and loss of AQP4 in the brain ventricular ependymal layer and astrocytes. Kidins220 is a known cargo of the SNX27-retromer, a complex that redirects endocytosed plasma membrane proteins (cargos) back to the cell surface, thus avoiding their targeting to lysosomes for degradation. Mechanistically, we show that AQP4 is a novel cargo of the SNX27-retromer and that Kidins220 deficiency promotes a striking and unexpected downregulation of the SNX27-retromer that results in AQP4 lysosomal degradation. Accordingly, SNX27 silencing decreases AQP4 levels in wild-type astrocytes whereas SNX27 overexpression restores AQP4 content in Kidins220 deficient astrocytes. Together our data suggest that the KIDINS220-SNX27-retromer-AQP4 pathway is involved in human ventriculomegaly and open novel therapeutic perspectives., This work was supported by Spanish grants SAF2017-88885-R to TI and SAF2017-88881-R to MRC from the Spanish Ministerio de Economía y Competitividad/Agencia Estatal de Investigación/European Union Funds for Regional Development (MINECO/AEI/ FEDER, EU); by Comunidad de Madrid through the European Social Fund (ESF)-financed programme NEUROMETAB-CM (B2017/BMD-3700) to TI and AORTASANA-CM (B2017/BMD-3676) to MRC; by ‘La Caixa’ Banking Foundation project HR18-00068 to MRC; by Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED, Instituto de Salud Carlos III, Spain) CB06/05/1122 to TI and collaborative grant CIBERNED PI2018/06 to TI and IFa; by grant PID2019-104763RB-100 and Ramón y Cajal programme contract (RYC-2014-15991), both from MINECO/AEI/FEDER (EU) to EP; by Wellcome Trust Senior Investigator Award (107116/Z/15/Z), the European Union’s Horizon 2020 Research and Innovation programme under grant agreement 739572 and a UK Dementia Research Institute Foundation award, all to GS; by grant PI19/00778 to AJJ from the Spanish Instituto de Salud Carlos III, co-funded by FEDER (EU); by Spanish grants from FEDER/Ministerio de Ciencia e Innovación (MICI)–AEI (SAF2017-86690-R), Network of Excellence iDIFFER (RED2018-102723-T), Instituto de Salud Carlos III (CIBERNED CB06/05/0086 and RETIC Tercel RD16/0011/0017) and Generalitat Valenciana (Prometeo 2017/030) to IFa. ADP was funded by a Juan de la Cierva Formación programme contract (FJCI-2014-19673; MINECO) and CIBERNED; JP-U was contracted by SAF2017-88885-R grant; AS-S was contracted by grants CIBERNED-PI2015-2/06 and PI2018/06, and SAF2017-88885-R; AS-G was funded by a contract from B2017/BMD-3700 grant and LSMP by a PhD training contract (PRE2018-086989) associated to grant SAF2017-88885-R.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Aortic disease in Marfan syndrome is caused by overactivation of sGC-PRKG signaling by NO

  • de la Fuente-Alonso, Andrea
  • Toral, Marta|||0000-0001-5324-8569
  • Alfayate, Alvaro
  • Ruiz-Rodríguez, María Jesús|||0000-0002-9317-8646
  • Bonzon-Kulichenko, Elena|||0000-0003-0852-7520
  • Teixido-Tura, Gisela|||0000-0003-4714-2420
  • Martínez-Martínez, Sara
  • Méndez-Olivares, María José
  • López-Maderuelo, Dolores
  • González-Valdés, Ileana
  • Garcia-Izquierdo, Eusebio
  • Mingo, Susana
  • Martín, Carlos E.
  • Muiño-Mosquera, Laura
  • De Backer, Julie|||0000-0001-8878-1507
  • Nistal, J. Francisco|||0000-0002-4152-7621
  • Forteza, Alberto
  • Evangelista Masip, Arturo|||0000-0001-8182-1174
  • Vázquez, Jesús|||0000-0003-1461-5092
  • Campanero, Miguel R.|||0000-0003-1410-8621
  • Redondo, Juan Miguel|||0000-0001-5779-9122
Thoracic aortic aneurysm, as occurs in Marfan syndrome, is generally asymptomatic until dissection or rupture, requiring surgical intervention as the only available treatment. Here, we show that nitric oxide (NO) signaling dysregulates actin cytoskeleton dynamics in Marfan Syndrome smooth muscle cells and that NO-donors induce Marfan-like aortopathy in wild-type mice, indicating that a marked increase in NO suffices to induce aortopathy. Levels of nitrated proteins are higher in plasma from Marfan patients and mice and in aortic tissue from Marfan mice than in control samples, indicating elevated circulating and tissue NO. Soluble guanylate cyclase and cGMP-dependent protein kinase are both activated in Marfan patients and mice and in wild-type mice treated with NO-donors, as shown by increased plasma cGMP and pVASP-S239 staining in aortic tissue. Marfan aortopathy in mice is reverted by pharmacological inhibition of soluble guanylate cyclase and cGMP-dependent protein kinase and lentiviral-mediated Prkg1 silencing. These findings identify potential biomarkers for monitoring Marfan Syndrome in patients and urge evaluation of cGMP-dependent protein kinase and soluble guanylate cyclase as therapeutic targets. Aortic aneurysm and dissection, the major problem linked to Marfan syndrome (MFS), lacks effective pharmacological treatment. Here, the authors show that the NO pathway is overactivated in MFS and that inhibition of guanylate cyclase and cGMP-dependent protein kinase reverts MFS aortopathy in mice